市场调查报告书
商品编码
1532133
印度维生素D补充剂市场评估:依类似物、依成分、依销售方式、依剂型、依治疗用途、依最终用户、依地区、机会、预测(2018年度-2032年度)India Vitamin D Supplements Market Assessment, By Analog, By Source, By Sales Method, By Dosage Form, By Therapeutic Applications By End-user, By Region, Opportunities and Forecast, FY2018-FY2032F |
印度维生素D补充剂市场规模预计将从2025年度的1.0104亿美元增至2032年度的1.8841亿美元,预计在2025年度至2032年度的预测期内年复合成长率为8.10%。维生素D缺乏症盛行率的上升、人们对补充剂及其在维持健康方面的作用的认识不断提高、主要市场参与者推出新产品以及提高公众意识的努力推动了市场的成长。
此外,印度保健补充剂的普及也支持了市场成长。2022年9月,Apollo Hospitals Group旗下的Apollo Pharmacy宣布在印度开设第5,000家门市。这种扩张预计将增加各种含有维生素D的保健品的销售机会,为市场提供有利的成长机会。
主要市场参与者加大努力改善警察的健康和福利也对市场扩张产生正面影响。2021年 7月,Fermenta Biotech Limited 向马哈拉施特拉邦警方捐赠了维生素D3胶囊,作为Help Protect Our Protectors计画的一部分。总共捐赠了 160 万粒胶囊来帮助军人增强免疫系统,因为维生素D在降低呼吸道感染风险和支持免疫力方面发挥着重要作用。
维生素D缺乏症的增加刺激了市场需求
印度维生素D缺乏症的盛行率日益增加,是推动印度维生素D补充剂市场需求的主要因素之一。 Nature发表的一篇论文估计,印度约有 4.9亿人缺乏维生素D,其中 31%是青少年和儿童。这种增加可能是由于阳光照射不足、阻碍紫外线穿透的污染、不良饮食和咖啡因摄取过多所造成的。由于人们越来越认识到与维生素D缺乏相关的各种不利影响以及膳食补充剂的日益普及,预计未来几年市场需求将会增加。人们对自己的健康变得更加积极主动,并开始寻求各种补充剂来支持他们的健康并解决各种营养缺乏问题。此外,政府加强应对维生素D缺乏症以及实施基于人口的干预和教育策略预计将支持市场扩张。
新产品发布促进市场成长
各家公司加强投资力度,在印度推出新型保健补充剂,预计将扩大印度维生素D补充剂的市场规模。2023年 7月,Oriflame India宣布在印度推出 Wellosophy 系列的两种新保健补充剂:镁强化钙、维生素D和铁复合物。这些补充剂可帮助保持积极、健康的生活方式并支持忙碌的日常生活,由瑞典营养委员会经过广泛研究和开发而开发。此类产品的推出,以及人们对膳食补充剂各种益处的认识不断提高,推动市场需求,并预计将对未来几年的市场扩张产生积极影响。此外,随着人们健康意识的提高以及对维生素D补充剂各种益处的认识的提高,预计将在预测期内显着增加市场需求。
维生素D3预计将占据主要市场占有率
这个细分市场的扩张是由于人们越来越认识到维生素D3的各种健康益处,包括改善钙吸收、改善骨骼健康、情绪调节和改善免疫功能。此外,生活方式的改变和室内方向的增加也增加了对维生素D3的需求。因此,每天补充维生素D3被全国各地的人们提倡。此外,维生素D3补充剂的供应量不断增加、不同口味的多种选择以及服用维生素D3补充剂的便利性推动这一细分市场的成长。 Carbamide Forte 提供 维生素D3 60000 IU 咀嚼片。该药每週服用一次,有橘子味。
本报告研究和分析了印度维生素D补充剂市场,提供市场规模和预测、市场动态、主要参与者的现状和前景等。
India Vitamin D supplements market is projected to witness a CAGR of 8.10% during the forecast period FY2025-FY2032, growing from USD 101.04 million in FY2025 to USD 188.41 million in FY2032. The growth of the market is supported by the rising prevalence of vitamin D deficiency, increasing awareness about supplements and their role in maintaining health, novel launches by key market players, and increasing government initiatives to enhance public awareness.
Additionally, the growth of the market is supported by the increasing accessibility to health supplements in India. In September 2022, Apollo Pharmacy, which is a part of the Apollo Hospitals Group, announced the opening of their 5000th outlet in India. Such expansions are expected to augment the accessibility to different health supplements including vitamin D and provide lucrative growth opportunities to the market.
Also, the increasing efforts of major market players to enhance the health and the well-being of police personnel is positively influencing the market's expansion. In July 2021, Fermenta Biotech Limited donated vitamin D3 capsules as part of the Help Protect Our Protectors initiative for Maharashtra Police. In total 1.6 million capsules were donated to allow the personnel to strengthen their immunity as vitamin D reduces the risk of respiratory infections and plays a crucial role in providing immune support.
Increasing Vitamin D Deficiency Boosts Market Demand
The rising incidences of Vitamin D deficiency in India is one of the major factors bolstering the India Vitamin D supplements market demand. According to the estimates of an article published in Nature, approximately 490 million individuals in India have vitamin D deficiency, of which 31% are adolescents and children. The increase can be attributed to inadequate exposure to sunlight, pollution hampering penetration of ultraviolet rays, dietary insufficiencies, and high intake of caffeine. The market demand is expected to increase in the coming years due to the growing awareness about the various negative effects associated with deficiency of vitamin D and the growing popularity of health supplements. The population is becoming more proactive about their health and is leaning on various supplements for supporting their well-being and addressing various nutritional deficiencies. Additionally, increasing government initiatives and implementation of population-based interventional and educational strategies for combating vitamin D deficiencies are expected to support the market's expansion.
Novel Launches Support Market Growth
The rising investments by various companies towards the introduction of new health supplements in the country is expected to increase the India Vitamin D supplements market size. In July 2023, Oriflame India announced the launch of two new health supplements under their Wellosophy range, calcium fortified with magnesium, vitamin D, and iron complex in India. These supplements aid in maintaining active and healthy lifestyles and support busy routines developed after extensive research and development by the company's nutrition council in Sweden. Such launches, coupled with the growing awareness about various advantages associated with health supplements, are propelling the market demand and are expected to positively influence the expansion of the market in the coming years. Additionally, due to the increasing health consciousness among the population and rising awareness about different benefits associated with vitamin D supplements is expected to increase market demand significantly over the forecast period.
Vitamin D3 Expected to Account Significant Market Share
The expansion of the segment is supported by the growing awareness about various health benefits offered by vitamin D3 including improved calcium absorption, which aids in improving bone health, mood regulation, and improved immune functions. Additionally, the requirement for vitamin D3 is rising due to changes in lifestyle and increased preference for indoors. Thus, propelling the adoption of Vitamin D3 supplements in daily regimens by various individuals across the country. Moreover, the increasing accessibility to these supplements and availability of a wide range of options in varying flavors coupled with easy to consume nature of these supplements is bolstering the growth of the segment. Carbamide Forte offers Vitamin D3 60000 IU chewable tables that are required to be consumed only once a week and are available in orange flavor.
Prescription Anticipated to Hold Significant Market Share
The requirement for vitamin D prescription is increasing in India due to the rising cases of vitamin D deficiency, increasing emphasis on maintaining bone health, expansion of the geriatric population, and rapid population growth. The increasing prevalence of vitamin D deficiency in children is expected to boost the expansion of the segment. According to a multicenter study published in Nature, the prevalence of vitamin D deficiency in children and adolescents ranged from 30%-98% in West India. Additionally, vitamin D deficiency is often associated with a higher risk of heart failure and vitamin D, assuming a protective role against cardiovascular diseases, thus propelling the requirement for vitamin D prescriptions. Various findings have shown that vitamin D could reduce the occurrence of cardiovascular events such as coronary revascularization and myocardial infraction.
Future Market Scenario (FY2025 - FY2032F)
The demand of the India Vitamin D supplements market is expected to increase significantly in the coming years due to the growing awareness about the various advantages associated with the supplements, rising prevalence of Vitamin D deficiency, and increasing expenditure on health supplements. The rising awareness about the role of Vitamin D in regulating the amount of phosphate and calcium in blood is expected to further bolster their consumption as these nutrients aid in maintaining the muscle, teeth, and bone health and lack of vitamin D can cause conditions such osteomalacia and bone deformities.
Key Players Landscape and Outlook
The growth of India Vitamin D supplements market is supported by the rising investments by the key market players towards the introduction of novel solutions in the country for effectively treating Vitamin D deficiency. In February 2024, Cadila Pharmaceuticals Limited launched the first aqueous Vitamin D injection which is expected to revolutionize the Vitamin D treatment. This development is expected to improve patient care by increasing the efficacy of the treatment and ensuring a painless and simple administration procedure. Such innovations are anticipated to enhance treatment outcomes and allow healthcare professionals to meet the unmet medical requirements of the patients.
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.